Aligos Therapeutics, Inc. (ALGS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-05) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-06) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-10) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-06) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-07) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-12) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations and Comprehensive (loss) Income | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Changes In Stockholders' Equity (deficit) | — |
|
| Consolidated Statements of Changes In Stockholders' (deficit) Equity | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Liabilities | ||
| Balance Sheet Components | ||
| Benefit Plans | — |
|
| Capital Stock | ||
| Commitments and Contingencies | ||
| Common Warrants and Pre Funded Warrants | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Equity Incentive Awards and Stock-based Compensation | — |
|
| Fair Value | — |
|
| Fair Value Measurements | ||
| In-licensing Agreements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Investment | ||
| Leases | — |
|
| License and Collaboration Agreements | ||
| Net (loss) Income Per Share | — |
|
| Net Income (loss) Per Share | — |
|
| Net Loss Per Share | ||
| Organization | ||
| Organization and Basis of Presentation | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment | ||
| Revenue | — |
|
| Revenue From Contracts With Customers | ||
| Segment Information | ||
| Short-term Investments | — |
|
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||